LEXICON
No.16 October 18, 2010

Limit on the prescription period
投与期間制限
Ban on long-term prescription
長期投与(処方)禁止
“Lifting of the ban on long-term prescription”or “lifting of the 2-week limit on the prescription period”
長期投与(処方)解禁

投与期間制限 (limit on the prescription period): The maximum prescription period, or the longest period for which a drug is allowed to be prescribed/dispensed at a time, is set at 14, 30 or 90 days for oral and topical drugs designated...

To read the full story

LEXICON

By Izuru Ando

A year has passed since the Ministry of Health, Labor and Welfare (MHLW) announced its package strategy to fuel the early commercialization of software as a medical device (SaMD) in November last year. A growing number of drug makers are…

By Philip Carrigan

Remember what it was like back in March, when we all started working from home? There was a distinct change in the air - a sense of freedom and excitement about the novelty of being able to work from home.…

The average ratio of female employees at managerial posts stood at just 12.5% at pharmaceutical companies operating in Japan, a Jiho survey revealed. While foreign drug makers had an average 25.0%, the ratio came to as low as 9.8% for…

By Yoshinori Sagehashi

Biogen’s controversial Alzheimer’s drug aducanumab was filed for Japanese regulatory approval in December. If approved, it will be the first…

Japan’s key reimbursement policy panel on December 20 approved an outline of its FY2020 drug pricing reform next April, with…

Japan will go ahead with the introduction of a cost-effectiveness assessment (CEA) scheme for drugs and medical devices in April…